Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
Wafik El-Deiry shared a few must-reads paper on X:
Imatinib and the dawn of precision cancer therapy
Author: Brian J. Druker
Authors: Ema Mitsui et al.
Authors: Martina Sanlorenzo et al.
Authors: Christian Kurzeder et al.
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
Authors: Mayra Shanley et al.
